1. Distinct Ring1b complexes defined by DEAD-box helicases and EMT transcription factors synergistically enhance E-cadherin silencing in breast cancer
   Yawei Wang et al, 2021, Cell Death & Disease CrossRef
2. ETS1 targets RYBP transcription to inhibit tumor cell proliferation
   Wen Zhao et al, 2019, Biochemical and Biophysical Research Communications CrossRef
3. Upregulation of circRNA hsa_circ_0008726 in Pre-eclampsia Inhibits Trophoblast Migration, Invasion, and EMT by Regulating miR-345-3p/RYBP Axis
   Chang Shu et al, 2022, Reproductive Sciences CrossRef
4. Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer
   Guan-Jun Dong et al, 2022, International Journal of Molecular Sciences CrossRef
5. RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity
   Takashi Morinaka et al, 2023, International Journal of Oncology CrossRef
6. Epigenetic and non-epigenetic functions of the RYBP protein in development and disease
   Carolina J. Simoes da Silva et al, 2018, Mechanisms of Ageing and Development CrossRef
7. RYBP modulates embryonic neurogenesis involving the Notch signaling pathway in a PRC1-independent pattern
   Qian Li et al, 2021, Stem Cell Reports CrossRef
8. RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
   Apostolos Zaravinos et al, 2018, Cancers CrossRef
9. Mechanisms of Polycomb group protein function in cancer
   Victoria Parreno et al, 2022, Cell Research CrossRef
10. The Potential Mechanism of Bufadienolide-Like Chemicals on Breast Cancer via Bioinformatics Analysis
    Yingbo Zhang et al, 2019, Cancers CrossRef
11. Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance
    Nadire Özenver et al, 2020, Prognostic and Therapeutic Applications of RKIP in Cancer CrossRef
12. Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathway
    Ai‐Hua Tong et al, 2019, Journal of Biochemical and Molecular Toxicology CrossRef
13. Low Expression of the Polycomb Protein RING1 Predicts Poor Prognosis in Human Breast Cancer
    Song Gao et al, 2021, Frontiers in Oncology CrossRef
14. Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells
    Eliana Noelia Alonso et al, 2018, Oncotarget CrossRef
15. In silico analysis of the potential mechanism of telocinobufagin on breast cancer MCF-7 cells
    Yi-wu Dang et al, 2018, Pathology - Research and Practice CrossRef
16. YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2
    Zhen Yang et al, 2021, Cancer Biology & Therapy CrossRef
17. Ring1 promotes the transformation of hepatic progenitor cells into cancer stem cells through the Wnt/β‐catenin signaling pathway
    Kai Zhu et al, 2020, Journal of Cellular Biochemistry CrossRef
18. Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours
    Koichiro Kajiura et al, 2017, Lung Cancer CrossRef
19. RYBP Is a K63-Ubiquitin-Chain-Binding Protein that Inhibits Homologous Recombination Repair
    Mohammad A.M. Ali et al, 2018, Cell Reports CrossRef
20. RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase transition process
    Yue Ke et al, 2020, Life Sciences CrossRef
21. RYBP Sensitizes Cancer Cells to PARP Inhibitors by Regulating ATM Activity
    Deanna V. Maybee et al, 2022, International Journal of Molecular Sciences CrossRef
22. Multiple roles of Ring 1 and YY1 binding protein in physiology and disease
    Shaohua Zhan et al, 2018, Journal of Cellular and Molecular Medicine CrossRef